Uremic Toxins and Cardiovascular Risk in Chronic Kidney Disease: What Have We Learned Recently beyond the Past Findings?

Patients with chronic kidney disease (CKD) have an elevated prevalence of atheromatous (ATH) and/or non-atheromatous (non-ATH) cardiovascular disease (CVD) due to an array of CKD-related risk factors, such as uremic toxins (UTs). Indeed, UTs have a major role in the emergence of a spectrum of CVDs,...

Descripción completa

Detalles Bibliográficos
Autores principales: El Chamieh, Carolla, Liabeuf, Sophie, Massy, Ziad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028122/
https://www.ncbi.nlm.nih.gov/pubmed/35448889
http://dx.doi.org/10.3390/toxins14040280

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028122/
https://www.ncbi.nlm.nih.gov/pubmed/35448889
http://dx.doi.org/10.3390/toxins14040280

Ejemplares similares